# ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

> **NCT05368038** · — · ENROLLING_BY_INVITATION · sponsor: **Albert Einstein College of Medicine** · enrollment: 100000 (estimated)

## Conditions studied

- Acid Sphingomyelinase Deficiency
- Ceroid Lipofuscinosis, Neuronal, 2
- Cerebrotendinous Xanthomatosis
- Fabry Disease
- GM1 Gangliosidosis
- Gaucher Disease
- Lysosomal Acid Lipase Deficiency
- Metachromatic Leukodystrophy
- Mucopolysaccharidosis II
- Mucopolysaccharidosis III-B
- Mucopolysaccharidosis IV A
- Mucopolysaccharidosis VI
- Mucopolysaccharidosis VII
- Niemann-Pick Disease, Type C

## Interventions

- **DIAGNOSTIC_TEST:** Confirmatory Testing

## Key facts

- **NCT ID:** NCT05368038
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-05-10
- **Primary completion:** 2029-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05368038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05368038, "ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT05368038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*